Researchers develop wireless implantable vascular monitoring system
Vascular diseases are public enemy number one: the leading killers worldwide, accounting for nearly a third of all human deaths on the planet.
May 12, 2022
0
72
Vascular diseases are public enemy number one: the leading killers worldwide, accounting for nearly a third of all human deaths on the planet.
May 12, 2022
0
72
Therapies based on engineered immune cells have recently emerged as a promising approach in the treatment of cancer. Compared to traditional drugs, engineered immune cells are more precise and sophisticated in their ability ...
Apr 15, 2022
0
27
Using their novel organ-on-a-chip platform, a research team from the University of Toronto's Faculty of Applied Science & Engineering has identified a molecule with the potential to combat one of the most severe complications ...
Mar 28, 2022
0
26
After a traumatic accident, there is a small window of time when medical professionals can apply lifesaving treatment to victims with severe internal bleeding. Delivering this type of care is complex, and key interventions ...
Mar 17, 2022
0
95
The European Commission on Monday authorised a vaccine from US company Novavax as its fifth official jab for use across the European Union, hours after the EU medicines watchdog gave approval.
Dec 20, 2021
0
3
The EU's drug regulator will decide Monday whether to approve a COVID jab by Novavax, which uses a more conventional technology that the US biotech firm hopes will reduce vaccine hesitancy.
Dec 20, 2021
0
2
A team of University of Arizona researchers has developed an ultra-thin wireless device that grows to the surface of bone and could someday help physicians monitor bone health and healing over long periods. The devices, called ...
Nov 23, 2021
0
87
The ability of SARS-CoV-2 to infect cells depends on interactions between the viral spike protein and the human cell surface protein ACE2. To enable the virus to hook onto the cell surface, the spike protein binds ACE2 using ...
Nov 4, 2020
0
261
An Imperial team has repurposed robotic technology normally used for synthetic biology research to help with testing for COVID-19.
Sep 9, 2020
0
62
Researchers from CSIRO, Australia's national science agency, have accomplished a world-first by processing one trillion points of genomic data through VariantSpark, an artificial intelligence-based platform, which can help ...
Sep 2, 2020
0
3